Get access

Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions

Authors


  • We describe the case of a breast cancer patient who developed dexrazoxane-induced anaphylaxis.

No abstract is available for this article.

Ancillary